COMMUNIQUÉ DE PRESSE publié le 14/02/2024 à 15:00, il y a 2 années 5 mois CUBE 3 Welcomes Industry Veteran, Nico Flannery-Pitcher, as Principal, Director of Interior Design CUBE 3 expands leadership with Nico Flannery-Pitcher joining as Principal and Director of Interiors, showcasing commitment to design innovation and excellence across business sectors Interior Design CUBE 3 Nico Flannery-Pitcher Design Innovation Business Sectors
COMMUNIQUÉ DE PRESSE publié le 13/02/2024 à 16:00, il y a 2 années 5 mois CUBE 3 Architecture Named Title Sponsor for Trans Am's TA2 Series in 2024 CUBE 3 Architecture partners with Trans Am Series as exclusive architectural firm, becoming title sponsor of TA2 Series for 2024 racing season Partnership CUBE 3 Architecture Trans Am Series TA2 Series Architecture
Publié le 10/08/2026 à 09:22, il y a 46 minutes Number of shares and voting rights - July 2026 (In French only)
Publié le 10/08/2026 à 09:22, il y a 46 minutes Nombre total d'actions et droits de vote - juillet 2026
Publié le 10/08/2026 à 07:00, il y a 3 heures 8 minutes BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Publié le 10/08/2026 à 07:00, il y a 3 heures 8 minutes Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Publié le 10/08/2026 à 08:00, il y a 2 heures 8 minutes Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Publié le 10/08/2026 à 08:00, il y a 2 heures 8 minutes Results of AGM and Management Update Presentation
Publié le 07/08/2026 à 23:15, il y a 2 jours 10 heures Faraday Copper Reports Second Quarter 2026 Financial Results
Publié le 07/08/2026 à 23:00, il y a 2 jours 11 heures Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Publié le 10/08/2026 à 09:50, il y a 18 minutes Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Publié le 10/08/2026 à 09:00, il y a 1 heure 8 minutes Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Publié le 10/08/2026 à 09:00, il y a 1 heure 8 minutes Original-Research: Bittium Oyj (von NuWays AG): BUY
Publié le 10/08/2026 à 09:00, il y a 1 heure 8 minutes Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients